Black Cumin Oil | The most important answers first

Why this article was created | What customers tell me

I would like to explain openly here why this topic occupies me so much in the first place.

Customers have repeatedly reported negative experiences or poor tolerance in connection with black cumin oil.

Green Agora did not collect these experiences as part of a study.

There is:

• no standardized questionnaire
• no defined participant group
• no uniform dosage
• no standardized products
• no control group
• no medical verification of all reported complaints

Therefore, I cannot infer from these conversations:

"Black cumin oil causes these complaints."

Or:

"These side effects occur frequently."

That would not be scientifically justified.

What I can say is:

For me, this feedback was a reason not to treat safety issues as a minor matter.

And that is exactly why I began to take case reports, meta-analyses, toxicological papers, and studies on drug interactions just as seriously as positive studies on blood sugar or cholesterol.

What is black cumin?

The true black cumin bears the botanical name:

Nigella sativa.

It belongs to the Ranunculaceae family.

Botanically, black cumin is neither common caraway nor cumin.

The black seeds are traditionally used as a spice and for various preparations.

A fatty vegetable oil can be extracted from the seeds.

This typically contains a high proportion of unsaturated fatty acids.

In an analysis of a cold-pressed oil cited in the Freiburg review, for example, there were approximately:

• 55 percent linoleic acid
• 24 percent oleic acid
• 15 percent palmitic acid

present.

These values are not a fixed composition of every black cumin oil.

Particularly well-known for pharmacological research is:

Thymoquinone | TQ.

Thymoquinone is one of the biologically active accompanying substances of Nigella sativa and is being intensively studied.

The first important difference | Nigella sativa is not the same as black cumin oil

Anyone reading the research will find very different interventions.

• whole seeds
• ground seeds
• seed powder
• capsules
• cold-pressed seed oil
• various extracts
• volatile or essential fractions
• isolated thymoquinone

These interventions are not interchangeable.

If a study, for example, investigates 2 g of seed powder, that is not a study with 2 g of black cumin oil.

If isolated thymoquinone influences a signaling pathway in a cell culture, that does not automatically prove the same effect after drinking a commercially available black cumin oil.

Also, the dose of an isolated substance cannot simply be transferred to a teaspoon of oil.

This is exactly where many exaggerations arise on the internet.

The positive research exists | And it must be mentioned

Personally, I think little of drinking black cumin oil as a precautionary daily health routine.

But that should not mean that I suppress positive research.

Nigella sativa is biologically active and has been studied in numerous human studies.

In 2025, a large systematic review with meta-analysis was published.

Included were:

82 studies with a total of 5,026 participants.

The studies lasted between:

1 and 48 weeks.

Different Nigella sativa preparations and dosages were investigated.

The authors reported statistically significant changes in various cardiometabolic risk factors.

These included, among others:

• fasting blood sugar
• HbA1c
• blood pressure
• total cholesterol
• LDL cholesterol
• triglycerides
• some inflammatory markers
• anthropometric parameters
• individual liver and kidney parameters

This is relevant clinical research.

Therefore, the assertion:

"Nigella sativa shows no measurable effects in humans at all."

would not be correct.

Many studies do not automatically mean high certainty of evidence

An important counterpoint comes from a review published in 2023.

There, not individual studies, but:

20 already published meta-analyses

were methodologically evaluated.

Using AMSTAR 2, the following were classified:

• 1 meta-analysis as moderate
• 4 as low
• 15 as critically low

The certainty of the evidence was also examined using GRADE.

Of 110 evaluated endpoints, there were:

• 5 moderate
• 17 low
• 88 very low

Key problems included:

• risk of bias
• inconsistency
• imprecision

For me, this is one of the most important findings of the entire topic.

A large number of publications is not automatically the same as high certainty about how strong an effect actually is, in whom it occurs, and which specific intervention is responsible for it.

Biomarkers are not the same as clinical endpoints

Many black cumin studies examine laboratory values or risk factors.

That makes scientific sense.

But false translations arise quickly.

A lowered LDL value does not automatically prove:

fewer heart attacks.

A changed HbA1c value does not automatically prove:

fewer diabetes complications.

A changed inflammatory marker does not automatically prove:

that a chronic disease has been treated or cured.

Biomarkers, risk factors, and hard clinical endpoints are different levels of evidence.

Blood sugar | A potential effect can also become practically relevant

An updated meta-analysis from 2024 examined 30 randomized studies.

In the overall result, changes were observed in:

• fasting blood sugar
• HbA1c

observed.

For insulin and HOMA-IR, however, there were no corresponding significant overall effects.

An important point was:

The heterogeneity between the studies was very high.

The studies, therefore, by no means all showed the same effect.

Especially for people who are already using:

• insulin
• oral antidiabetics
• other blood-sugar-lowering drugs

a safety issue also arises.

If an additional substance influences glucose metabolism, potential additive effects can become relevant.

This does not mean that black cumin oil causes hypoglycemia in every person on diabetes medication.

But a biologically active intervention should not automatically be considered ineffective against an existing therapy.

Blood pressure | Small average changes, major individual questions

An updated meta-analysis from 2023 reported, on average, changes in blood pressure in the order of approximately:

3.1 mmHg systolic

and:

2.7 mmHg diastolic.

Here, too, the heterogeneity between the studies was high.

For someone without blood pressure medication, such a research finding might initially sound positive.

With existing drug treatment, the question also arises:

Could effects add up?

For many specific combinations, sufficient clinical interaction studies are missing.

Blood lipids | Positive meta-analysis, but no automatic prevention

A 2024 meta-analysis examined 34 studies with a total of 2,278 participants.

Overall, changes were reported in:

• Total cholesterol
• LDL cholesterol
• Triglycerides
• HDL cholesterol

reported.

This is also relevant clinical research.

However, it does not automatically prove a reduction in heart attacks, strokes, or other hard cardiovascular endpoints.

Furthermore, different Nigella sativa preparations were pooled together.

Side effects | What clinical reviews actually report

The review of meta-analyses published in 2023 also includes information on safety.

In particular, the following were reported:

• Stomach pain
• Diarrhea
• Nausea
• Vomiting
• Weakness
• Weight loss

No serious adverse events were reported in the meta-analyses evaluated.

This is an important, reassuring finding.

At the same time, there was a methodological problem:

Adverse events were not sufficiently documented in many primary studies.

Therefore, the rule is:

Not reported does not automatically mean did not occur.

And the lack of serious events in small or short studies does not reliably rule out rare risks.

Short-term tolerability is not the same as long-term safety

Many Nigella sativa studies last only:

• four weeks
• eight weeks
• twelve weeks

Some investigations last longer.

In the large 2025 meta-analysis, individual studies ranged up to 48 weeks.

By contrast, people who consider black seed oil a permanent health routine may consume it for years.

An eight- or twelve-week study without a serious event does not automatically answer the question of daily intake over many years.

Particularly rare adverse events are difficult to capture in small studies anyway.

Kidneys | The scientific data point in both directions

When it comes to the kidneys, a particularly precise classification is necessary.

There are preclinical studies in which Nigella sativa or thymoquinone were associated with favorable effects on renal parameters.

Human studies and meta-analyses also sometimes report:

• no deterioration in creatinine
• improvements in individual kidney parameters
• lower urea levels in certain investigations

The large 2025 meta-analysis also reported changes in individual kidney parameters in favor of the intervention.

Therefore, the statement:

"Black seed oil fundamentally damages the kidneys."

would be false.

At the same time, there are published case reports that should be taken seriously as potential safety signals.

2013 | Case report of acute kidney failure

In 2013, a case report was published:

"A case study report of acute renal failure associated with Nigella sativa in a diabetic patient."

It was taken in addition to existing medication.

In the temporal context, the following was described:

acute kidney failure

was described.

A single case report cannot prove:

that Nigella sativa alone was the cause.

It also cannot show how frequently such an event occurs.

But such a case can be relevant as a:

safety signal

.

2024 | Rhabdomyolysis, acute kidney injury, and hepatotoxicity

In 2024, another case report was published in the professional journal Toxicon.

The title:

"Rhabdomyolysis and acute kidney injury after consumption of black seed oil."

After publication, the patient had taken:

2,000 mg of black seed oil per day

for approximately:

one month

.

The following were described:

• Rhabdomyolysis
• acute kidney injury
• hepatotoxicity

Rhabdomyolysis refers to severe damage to muscle cells.

This case, too, does not prove general causality and says nothing about the frequency of such events in the population.

However, it is a published safety signal that should be taken seriously.

Two case reports are not frequency statistics

I deliberately do not want to exaggerate here.

From two published kidney cases, one must not conclude:

"Black seed oil frequently causes kidney failure."

There is no scientific basis for this.

Case reports are not suitable for determining frequency.

However, they can draw attention to rare or unexpected events that would barely be visible in small randomized studies.

This is exactly the significance they should be given – no more, but no less.

Liver | Overall more reassuring data, but no complete free pass

The LiverTox database of the US National Library of Medicine evaluated black seed as not being associated with clinically apparent liver injury up to its update in April 2023.

This strongly argues against a blanket statement such as:

"Black seed oil is hepatotoxic."

However, the 2024 case published with rhabdomyolysis and acute kidney injury also described hepatotoxicity.

A balanced assessment is therefore:

Frequent clinical liver toxicity has not been proven. At the same time, there is now at least one more recent published case that should be taken into account as a possible safety signal.

Thymoquinone | Biologically interesting does not automatically mean harmless

Thymoquinone is one of the most intensively studied ingredients in Nigella sativa.

In experimental studies, influences are investigated on, among other things:

• oxidative signaling pathways
• inflammatory mechanisms
• cell proliferation
• enzyme systems
• immune processes

This biological activity is scientifically interesting.

But it is also a reason to take dosage and safety seriously.

For thymoquinone, as for other biologically active substances, the following applies:

The dose is part of the effect.

Experimental toxicological studies show that biological activity can, depending on the dose, also turn into undesirable or toxic effects.

The simple advertising formula:

"The more thymoquinone, the better."

is therefore scientifically unjustified.

There is no universal thymoquinone target value for consumers

Some black seed products advertise particularly high thymoquinone levels.

This quickly creates the perception of:

more active ingredient.

more effect.

more health benefit.

However, no generally accepted clinical rule of this kind exists.

A high thymoquinone content is primarily an analytical product characteristic.

It does not automatically prove:

• higher efficacy
• better long-term safety
• better tolerability
• an ideal individual dose

Drug interactions | One of the most important points for me

Many drugs are metabolized in the body via cytochrome P450 enzymes.

These include, for example:

• CYP2D6
• CYP3A4
• CYP2C9

If plant compounds influence such enzyme systems, the concentrations or degradation of simultaneously taken drugs could theoretically also be altered.

However, whether and to what extent this is clinically relevant must be investigated for the respective substance and combination.

Small human study | Influence on CYP2D6 and CYP3A4

A small human study investigated the question of drug metabolism.

The most important limitation:

Only four healthy people participated.

The participants received:

2.5 g of black cumin seeds twice daily

for seven days.

This corresponds to:

5 g of seeds per day.

Dextromethorphan was used as the test substance.

The results indicated an influence on:

• CYP2D6
• CYP3A4

.

This study is far too small to predict an interaction with every medication.

However, it argues against assuming as a general rule that Nigella sativa components fundamentally cannot influence drug metabolism.

Important | The CYP study examined seeds, not just any black seed oil

Here, too, the intervention must not be modified.

The subjects of the study were:

Black cumin seeds.

Not just any commercially available black seed oil.

The strength of the observed effect can therefore not be automatically transferred to every oil or capsule.

The study provides a potential interaction signal for Nigella sativa – not a universal interaction formula for every product.

Warfarin | Experimental signal, no clinical human evidence

Thymoquinone was also investigated with regard to CYP2C9 and warfarin metabolism.

Experimental data showed an inhibition of CYP2C9-dependent warfarin metabolism.

Warfarin has a narrow therapeutic index.

Therefore, such an observation is scientifically relevant.

But:

The experimental data do not yet prove a clinically relevant warfarin interaction in humans.

In the case of anticoagulation, however, self-administered high-dose intake of biologically active plant preparations is not an area for self-experimentation for me.

If taking medication regularly, I would not simply experiment

I would be particularly cautious with people on permanent medication.

For example, in connection with:

• diabetes
• blood pressure
• blood coagulation
• drugs with a narrow therapeutic index
• multiple medications taken simultaneously

This does not mean:

"Black seed oil is proven to interact with all these medications."

It means:

For many combinations, the available data are insufficient to confirm or rule out relevant interactions across the board.

Skin | Contact allergies are documented

Black seed oil is not only used orally.

It is also applied to the skin and scalp.

Allergic contact reactions to Nigella sativa oil are scientifically documented.

In dermatological studies, the following was also identified:

Thymoquinone

as a potential contact allergen.

2018 | Three serious acute skin reactions

A case series in JAMA Dermatology described three women with serious acute skin reactions after the topical application of Nigella sativa oil.

Descriptions included, among others:

• target-like skin lesions
• blisters
• fever
• pronounced skin detachment

In the patients, more than 15 percent of the skin was affected by detachment.

The oils used produced positive patch tests.

Here, too, these are rare documented cases and not a statement that black seed oil triggers serious skin reactions in most people.

Children | So far rather reassuring safety data, but limited evidence

In 2025, a systematic review on Nigella sativa in pediatrics was published.

15 clinical studies were included.

The meta-analysis showed no statistically significant cluster of adverse effects.

No serious adverse events were reported in the included studies.

This is a positive safety finding.

However, the authors emphasized at the same time that there are too few high-quality studies to definitively assess efficacy, optimal dose, suitable dosage form, and safety.

In individual studies, reports included, among others:

• nausea and vomiting
• diarrhea
• constipation
• skin rash

In a small study with children with epilepsy, increased seizures were observed in two participants.

Individual events should not be overdramatized. But they should also not disappear from a safety assessment.

Pregnancy | Missing human data is not a safety clearance

For pregnancy, many discussed safety data come from experimental or animal studies.

Such data can provide indications.

However, they do not reliably answer the question:

Is regular high-dose or medically motivated oral intake of black seed oil safe during a human pregnancy?

There is insufficient robust human data for such a blanket safety clearance.

Furthermore, a distinction must be made between:

small culinary quantities of black cumin seeds as a spice

and:

concentrated regular intake of oil, capsules, or extracts.

Product quality | One of the most important practical points

Even if a study with black seed oil is interesting, one crucial question remains:

Is the oil being studied even comparable to any commercial product?

In 2022, several commercial black seed oils and capsule products were examined for their thymoquinone content.

The measured range extended from:

3.08 to 809.4 mg of thymoquinone per 100 g.

This corresponds to a difference of more than a:

factor of 260.

That is huge.

Two products, each labeled "black seed oil," can have completely different compositions regarding a centrally discussed bioactive ingredient.

What does such product variation mean?

If someone says broadly:

"Take a teaspoon of black seed oil every day."

without additional analysis, it may not even be known:

• how much thymoquinone is contained
• what the composition of other volatile compounds is
• how the oil was processed
• how fresh it is
• how it was stored
• how far oxidation has progressed

Especially when health claims are being made regarding a bioactive ingredient, this product variation becomes relevant.

Origin and chemical composition also differ

A 2024 study compared Nigella sativa seed oils of different origins.

Among other things, the following were analyzed:

• fatty acid profiles
• tocopherols
• sterols
• volatile compounds
• quality parameters

The investigations showed clear differences between the oils.

The volatile components, including thymoquinone, also varied.

The label "black seed oil" alone therefore does not describe a fully standardized product.

Extraction and storage change black seed oil

Extraction processes and storage conditions also influence plant oils.

An investigation published in 2025 analyzed various:

• extraction methods
• storage conditions
• temperatures

and showed changes in various quality parameters.

I know this very well from my daily work with olive oil.

A plant oil is not a static product.

Light.

Oxygen.

Temperature.

Time.

All these factors play a role even after production.

Oxidation | Black seed oil is not an indefinitely stable oil

Black seed oil typically contains a high proportion of polyunsaturated fatty acids.

These are more susceptible to oxidation than monounsaturated fatty acids.

Therefore, among other things:

• production
• packaging
• storage
• temperature
• oxygen exposure
• age of the oil

are relevant.

Dark glass, for example, can protect against light.

But:

A dark bottle cannot fix oil quality that is already problematic.

2025 | A concrete product recall due to elevated PAH levels

In March 2025, a specific batch of black seed oil capsules was recalled in Austria.

The reason was:

elevated levels of polycyclic aromatic hydrocarbons | PAH.

The AGES explicitly recommended no longer taking the affected product.

This recall concerns a specific product and a specific batch.

It does not prove that black seed oil in general is contaminated with PAHs.

However, it shows:

Product quality and contaminants are a direct part of the safety assessment for dietary supplements and plant oils.

"Cold-pressed" is no proof of safety

The term:

cold-pressed

initially describes a method of production.

It does not automatically answer questions regarding:

• thymoquinone content
• oxidation state
• contaminants
• microbiological quality
• freshness
• storage conditions

A production term does not replace a comprehensive product analysis.

The dosage problem | What amount is actually supposed to "work"?

On the internet, you often find concrete intake recommendations.

One teaspoon.

Two teaspoons.

One capsule.

Twice daily.

The scientific literature is significantly more heterogeneous.

Investigated amounts include, among others:

• a few hundred milligrams
• 1 g
• 2 g
• 3 g
• 5 ml of oil
• several grams of seeds
• different extracts

Furthermore:

The preparations used do not have a uniform chemical composition.

Therefore, there is no universal, scientifically established dose of black seed oil for:

"health."

More is not automatically better

Regarding plant substances, I often encounter the idea:

If something is biologically interesting, more of it must be even better.

That is not how pharmacology works.

A dose-response relationship can:

• increase
• plateau
• have an optimal range
• develop undesirable effects above a certain exposure

More active ingredient is not automatically more health benefit.

Cell studies | Fascinating, but not human therapy

There is a lot of laboratory research on Nigella sativa and thymoquinone.

Studied subjects include, for example:

• cancer cells
• inflammatory pathways
• bacteria
• oxidative processes
• signal proteins
• cells of different organs

Such investigations can reveal mechanisms.

They can explain why a substance might be interesting for further research.

But:

A cell culture is not a human.

A substance that influences cancer cells in a petri dish does not automatically become an effective or safe cancer therapy.

Animal studies | Also not a direct therapy claim for humans

A significant portion of the spectacular Nigella sativa literature comes from animal models.

Models studied include, among others:

• diabetes
• kidney injury
• liver damage
• inflammation
• neurological diseases
• tumor diseases

This research is scientifically important.

However, dosage, metabolism, and disease models in animals can differ significantly from those in humans.

A positive effect in an animal model is not yet a clinically proven treatment in humans.

Tradition | Interesting, but not clinical proof of efficacy

Black seed has a long cultural and traditional history of use.

This can be scientifically and historically interesting.

But:

How long has something been used?

is not the same question as:

How well are efficacy, dosage, and safety clinically proven?

Tradition can inspire research questions.

It does not replace a controlled human study.

"Gold of the Pharaohs" | A strong story is not medical proof

Black seed is often referred to as the:

"Gold of the Pharaohs."

Such stories are memorable.

However, even a millennia-old use could not provide a modern answer to questions about:

• dosage
• drug interactions
• long-term safety
• kidney risks
• standardized product quality
• clinical efficacy

History can explain a research question. It does not replace the answer.

"Natural" means neither ineffective nor automatically harmless

Nature consists of chemistry.

Many pharmacologically active substances originate from plants or other natural sources.

Therefore, I consider two extreme statements to be wrong.

The first:

"It is natural, so it cannot do any harm."

The second:

"It is herbal, so it cannot have any effect at all."

Nigella sativa illustrates well why both simplifications are problematic.

There is:

• biological activity
• clinical signals
• documented side effects
• possible interactions
• large product differences
• open questions regarding long-term safety

The negative sides of black seed oil | What is actually documented

What this article explicitly does not claim

My personal skepticism should not be turned into a scientifically impermissible general statement.

This article does not claim:

• that every person gets complaints from black seed oil
• that black seed oil is generally toxic
• that kidney damage occurs frequently
• that black seed oil generally damages the liver
• that positive studies are meaningless
• that black cumin seeds as a spice are inherently dangerous
• that every intake automatically interacts with medications
• that the negative experiences reported by customers are scientifically proven product effects

The message is:

The scientific situation is significantly more complex than many simple health promises regarding black seed oil suggest.

Black cumin as a spice and black seed oil for self-therapy are not the same

The method of use also changes the context of the question.

A person uses a few black cumin seeds as a spice on bread or in a dish.

That is something different from:

• drinking concentrated oil every morning
• taking capsules
• using high-dose extracts
• using a product specifically to treat an illness

Dosage, product form, and purpose of intake are scientifically decisive.

Why Green Agora does not sell black seed oil

Green Agora does not currently stock black seed oil.

This is, first and foremost, a product range decision.

It is not an assertion that every black seed oil is bad, dangerous, or inferior.

My personal stance, however, is clear.

After my engagement with:

• the quality of effectiveness evidence
• the major product differences
• potential drug interactions
• limited long-term data
• documented side effects
• and individual severe safety signals

I personally see no convincing reason to recommend black seed oil as a general daily health routine.

This is my personal assessment of the current overall situation – not scientific proof that black seed oil is inherently harmful.

If future high-quality research leads to different results, such a personal assessment must also remain subject to review.

Legally, health claims are also clearly limited

Black seed oil is typically offered in commerce as a food or food supplement.

For food in the European Union, the following generally applies:

No properties for the prevention, treatment, or cure of human disease may be attributed to them.

This arises in particular from Article 7 of Regulation (EU) No 1169/2011.

This limit also applies to advertising.

Phrasings such as:

• "cures diabetes"
• "treats high blood pressure"
• "protects against cancer"
• "therapies allergies"
• "heals liver or kidney diseases"

are not permissible for a food product simply because experimental or clinical studies on individual biomarkers exist somewhere.

Botanical Health Claims | Particularly careful scrutiny required since the 2025 ECJ ruling

Health-related claims about food are additionally subject to the European Health Claims Regulation.

For botanical substances, a special situation existed for many years because numerous submitted claims had not yet been conclusively evaluated by the European Commission.

On:

April 30, 2025

the Court of Justice of the European Union in the case:

C-386/23 | Novel Nutriology

further clarified the legal classification of such botanical claims.

According to the ruling, food companies cannot freely use health-related claims regarding botanical substances whose assessment is not yet concluded simply because these claims are still "on hold."

Use is only considered if the requirements of the relevant transitional provisions are actually met.

General, non-specific health promises are also not automatically freely usable.

For Green Agora, this means:

Scientific research on Nigella sativa may be explained factually. However, this does not automatically create a permissible advertising claim for a food or food supplement.

How the EU checks health-related claims for food

For which people would I be particularly cautious?

I would question medically motivated self-use particularly critically for people:

• with existing kidney diseases
• with existing liver diseases
• with diabetes and blood-sugar-lowering medication
• taking blood pressure medication
• under anticoagulation
• taking medications with a narrow therapeutic index
• taking several long-term medications
• during pregnancy and breastfeeding
• in children
• with known severe contact allergies

This does not mean:

Black seed oil is provably dangerous for every person in these groups.

It means:

The decision here should not be based solely on an internet recommendation or a health promise.

When complaints should be taken medically seriously

Anyone using black seed oil or another food supplement and subsequently developing significant new symptoms should report the intake during a medical assessment.

Symptoms that should be professionally clarified, especially in acute or severe cases, include, for example:

• severe muscle pain
• pronounced muscle weakness
• dark urine
• significantly reduced urine volume
• persistent severe vomiting
• yellowing of the skin or eyes
• widespread skin rash
• blistering
• shortness of breath
• disturbances of consciousness
• symptoms of severe hypoglycemia

This section is not intended for self-diagnosis.

In the case of severe or acute symptoms, assessment belongs in medical hands.

Ayhan's classification | Why I view black seed oil critically

After this research, my personal position is clear.

Personally, I do not think much of drinking black seed oil as a precautionary daily health routine.

Not because I could claim:

"Black seed oil is inherently harmful."

I cannot do that based on the available data.

My skepticism arises from something else.

I see positive metabolic studies.

But I also see a partially low or very low certainty of evidence.

I see mostly good short-term tolerability.

But I see limited data on very rare and long-term risks.

I see biologically active ingredients.

But I also see possible drug interactions.

I see studies with favorable kidney parameters.

But I also see published cases of acute kidney injury.

I see mostly reassuring liver data.

But I also see a recently published case involving hepatotoxicity.

And I see products whose thymoquinone content can differ by more than 260 times.

Added to this are the repeated negative experiences that customers have personally reported to me.

These customer reports are not clinical proof.

But they have prompted me to look more closely.

And after looking more closely, my personal question is:

Why should a healthy person take a biologically active, non-uniformly standardized product as a precautionary daily self-therapy, when benefits, optimal dosage, product comparability, interactions, and long-term safety are not sufficiently clarified for every application?

For me personally, the answer is:

I see no convincing reason for this at the moment.

Ayhan Çabuk from Green Agora

My Conclusion | A major health promise requires strong evidence

Black cumin is scientifically interesting.

There is no question about that after my research.

Nigella sativa possesses biologically active ingredients.

Randomized studies and meta-analyses report changes in various metabolic parameters.

Thymoquinone is pharmacologically interesting.

And many clinical studies report overall decent short-term tolerability.

But precisely for this reason, black seed oil should not be treated as a completely neutral food as soon as it is specifically used in concentrated form to influence health problems.

We know of:

• mild documented side effects
• possible drug interactions
• allergic skin reactions
• major differences between commercial products
• limited long-term safety data
• and rare but serious case reports

At the same time, these risks should not be artificially inflated.

Two published kidney cases do not prove frequent kidney toxicity.

One case of hepatotoxicity does not make black seed oil generally liver-toxic.

Three severe skin reactions do not mean that most users react accordingly.

And negative customer feedback is not a controlled study.

But "natural" is not a free pass either.

For me, therefore, the following applies:

The greater the health promise, the stronger the evidence must be.

And:

If a substance is to be biologically active enough to exert relevant effects, dosage, side effects, and interactions must also be taken seriously.

My personal consequence therefore remains:

Green Agora does not sell black seed oil, and I personally see no convincing reason to recommend it blanketly as a daily health routine.

Anyone wishing to use it specifically due to an illness, medication intake, or health complaints should not base this decision solely on advertising claims or internet reports.

Ayhan Çabuk from Green Agora

Black seed oil | Frequently asked questions

Is black seed oil healthy?

Nigella sativa possesses biologically active ingredients, and human studies report changes in various metabolic parameters. This does not lead to a general statement that the daily intake of any black seed oil provides a health advantage for everyone.

Is black seed oil dangerous?

A blanket statement that black seed oil is inherently dangerous is not supported by the overall data. However, there are documented side effects, potential interaction signals, limited long-term data, and individual serious case reports.

Which side effects are described?

In clinical reviews, stomach problems, diarrhea, nausea, vomiting, weakness, and weight loss, among others, have been mentioned. In cases of external use, allergic contact reactions have been documented.

Have customers of Green Agora had negative experiences with black seed oil?

Ayhan reports that customers have repeatedly told him about negative experiences or poor tolerability in connection with black seed oil. These conversations were not systematically scientifically collected and prove neither cause nor frequency. However, they were a reason to investigate the safety literature more closely.

Does Green Agora sell black seed oil?

No. Green Agora does not currently stock black seed oil.

Can black seed oil damage the kidneys?

A general kidney-damaging effect is not proven. Controlled studies sometimes report neutral or favorable kidney parameters. At the same time, there are rare case reports of acute kidney injury or kidney failure in temporal association with Nigella sativa or black seed oil.

Can black seed oil damage the liver?

Frequent clinical liver toxicity is not proven. However, a case report from 2024 describes hepatotoxicity together with rhabdomyolysis and acute kidney injury.

Can black seed oil lower blood sugar?

Meta-analyses report average changes in fasting blood sugar and HbA1c under Nigella sativa interventions. However, the studies are heterogeneous and use different preparations. This is particularly relevant when taking blood-sugar-lowering medication at the same time.

Can black seed oil influence blood pressure?

Meta-analyses report small average blood pressure changes. The individual effect is not reliably predictable. With existing blood pressure therapy, additional targeted intake should be professionally assessed.

Can black seed oil interact with medications?

This is generally possible. A very small human study with black cumin seeds and experimental data show potential influences on certain cytochrome P450 enzymes. However, sufficient clinical interaction data is missing for many specific drugs and black seed oil products.

Can black seed oil interact with blood thinners?

There is experimental evidence for thymoquinone regarding an influence on CYP2C9-dependent warfarin metabolism. A clinically relevant interaction in humans has therefore not yet been proven.

Can black seed oil trigger allergies?

Yes. Allergic contact reactions upon external use are documented. Rare severe skin reactions have also been published.

Is thymoquinone automatically healthy?

Thymoquinone is a biologically active component of Nigella sativa. It does not follow that a higher amount automatically means more health benefits.

Is a high thymoquinone content automatically a quality feature?

It is, first of all, an analytical characteristic. It proves neither better clinical effect nor better individual tolerability.

Are all black seed oils the same?

No. Studies show significant differences in thymoquinone content as well as other ingredients and quality parameters.

Can black seed oil go rancid?

Yes. Black seed oil contains a high proportion of unsaturated fatty acids and can oxidize. Production, oxygen, light, temperature, storage, and time all play a role.

Is cold-pressed black seed oil automatically safer or better?

No. The term "cold-pressed" describes a production method and does not automatically answer questions regarding oxidation, thymoquinone content, contaminants, freshness, or storage quality.

Can one drink black seed oil regularly during pregnancy?

For medically motivated or higher oral amounts, sufficiently robust human safety data is missing. Small culinary amounts of black cumin seeds as a spice are to be distinguished from concentrated regular intake.

Is black seed oil suitable for children?

A review published in 2025 found no statistically significant accumulation of adverse effects in the included studies. However, the database is limited and heterogeneous, so no general medical dosage or safety approval should be derived from it.

Is black seed oil a medication?

Black seed oil sold as a food or dietary supplement is not an approved medicinal product for diabetes, high blood pressure, allergies, cancer, liver, kidney, or other diseases.

Why is Ayhan skeptical about black seed oil?

His personal skepticism is based on the combination of heterogeneous evidence, partially low certainty of evidence, large product differences, limited long-term data, potential drug interactions, documented side effects, and recurring negative customer feedback. This personal assessment is to be distinguished from a scientific statement that black seed oil is fundamentally harmful.

Professional Basis | Black seed oil, effect and safety

For this article, the Freiburg review as well as current systematic reviews, meta-analyses, human studies, case reports, analytical papers, and European legal sources were taken into account.

• Chrubasik-Hausmann S. | Black Cumin | Nigella sativa | Department of Phytotherapy, Institute of Forensic Medicine, University of Freiburg
• Li Z et al. | Nigella sativa and health outcomes | Overview of systematic reviews and meta-analyses | Frontiers in Nutrition | 2023 | PMID 37057067
• Jafari A et al. | Nigella sativa and cardiometabolic risk factors | 82 studies | 5,026 participants | Pharmacological Research | 2025 | PMID 40714301
• Shirvani S et al. | Nigella sativa and blood glucose control | updated meta-analysis of randomized studies | 2024 | PMID 39181437
• Kavyani Z et al. | Nigella sativa and blood pressure | systematic review and meta-analysis | 2023 | PMID 37341696
• Rounagh M et al. | Nigella sativa and lipid profile | 34 studies | 2,278 participants | meta-analysis | 2024 | PMID 38777430
• Mashayekhi-Sardoo H et al. | Nigella sativa black seed safety | toxicological review | PMID 37551386
• Arslan E et al. | Acute kidney injury associated with Nigella sativa | case report | 2013 | PMID 23464648
• Sener K et al. | Rhabdomyolysis and acute kidney injury following black seed oil | case report with additionally reported hepatotoxicity | Toxicon | 2024 | PMID 38844000
• Al-Jenoobi FI et al. | Nigella sativa and CYP2D6 or CYP3A4 | human and in vitro data | PMID 20201775
• Thymoquinone and potential warfarin interaction | experimental CYP2C9 investigation | PMID 35921950
• Gaudin O et al. | Severe acute contact dermatitis due to Nigella sativa oil | case series | JAMA Dermatology | 2018 | PMID 30073256
• Thymoquinone as a contact allergen in Nigella sativa oil | PMID 32232855
• Abumadini MM et al. | Clinical Uses of Nigella Sativa in Pediatrics | systematic review and meta-analysis | 2025 | PMID 41112345
• Khaikin E et al. | Thymoquinone content of commercial black seed products | Nutrients | 2022 | PMID 36079759
• Dąbrowski G et al. | Variation in composition and quality of Nigella sativa oils | Molecules | 2024 | PMID 38542995
• Doğan S et al. | Influence of extraction and storage on black seed oil | Food Chemistry | 2025 | PMID 41076879
• LiverTox | Black Cumin Seed | National Institute of Diabetes and Digestive and Kidney Diseases | Updated April 2023
• AGES | Recall of black seed oil 500 mg capsules due to elevated PAH levels | March 31, 2025
• Regulation (EU) No 1169/2011 | Article 7 | Prohibition of claims for disease prevention, treatment, and cure for food products
• Regulation (EC) No 1924/2006 | Nutrition and health claims on food products
• Court of Justice of the European Union | C-386/23 Novel Nutriology | Judgment of April 30, 2025 | Botanical health claims and transitional provisions

In the scientific classification, a deliberate distinction was made between:

Black cumin seeds | seed powder | black seed oil | extracts | thymoquinone | cell studies | animal studies | human studies | meta-analyses | case reports | customer feedback | product analyses.

These levels have different evidentiary weight and must not be mixed arbitrarily.